Antimicrobial office acting director
Executive Summary
CDER Office of Antimicrobial Drug Products Deputy Director Edward Cox is named acting director effective Aug. 21. Former director Mark Goldberger recently accepted a position in CBER as medical director for emerging and pandemic threat preparedness effective Aug. 20 (1"The Pink Sheet" July 24, 2006, In Brief). Division of Antiviral Drug Products Deputy Director Jeff Murray will serve as acting deputy director of OAP...
You may also be interested in...
...And with FDA
Former Center for Drug Evaluation & Research Office of Antimicrobial Products Director Mark Goldberger is appointed to the newly created position of Emergency & Pandemic Threat Preparedness Medical Director in the Center for Biologics Evaluation & Research, where he will guide development and evaluation of products related to pandemic threats...
Roche/Genentech Keeps Commitment To External Cancer Innovation
Roche/Genentech oncology partnering maintained a robust dealmaking pace through the pandemic, keeping the percentage of partnered R&D programs at about 50% of the cancer drug pipeline.
US FDA Eases Changes For Certain Sterile Injectable Container Closure Materials
To mitigate pandemic disruption of component supply chains, the US FDA said it will downgrade some post-approval change categories for sterile drug container closure systems. The downgrade will cover drugs in shortage and those used to treat COVID-19.
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: